Andra Hohler James, MD
I am an OB-GYN and a specialist in maternal-fetal medicine and high-risk obstetrics. My research and publications pertain mainly to the care of women with blood disorders (thrombosis and thrombophilia), bleeding disorders (including von Willebrand disease), platelet disorders (including ITP), and sickle cell disease.
Education and Training
- Associate, Obstetrics And Gynecology, Duke University, 1997 - 2000
- Resident, Obstetrics & Gynecology, North Carolina Memorial Hospital, 1993 - 1997
- M.D., University of Virginia, 1993
- M.P.H., Johns Hopkins University, 1977
Selected Grants and Awards
- Transfusion Medicine and Hematology
- Preventing venous thromboembolism following cesarean delivery: building evidence to inform practice
- A Multicenter Study on the Retrospective Safety and Efficacy of Fibrinogen Concentrate (Human) (FCH) for Routine Prophylaxis, Treatment of Bleeding or Surgery in Subjects with Congenital Fibrinogen Deficiency with a Prospective Followup Component
- Thrombosis and Hemostasis Centers Research and Prevention Network
- Integrated Program for Persons with Hemostatic Disorders
- The Obstetrics and Gynecology Risk Group
- CDC Menorrhagia Treatment Study
- CDC PO- IUGR Study
Ortel, T. L., A. H. James, E. H. Thames, K. D. Moore, and C. S. Greenberg. “Assessment of primary hemostasis by PFA-100 analysis in a tertiary care center.” Thromb Haemost 84, no. 1 (July 2000): 93–97.
Ortel, T. L., A. H. James, E. H. Thames, K. Moore, and C. S. Greenberg. “Assessment of primary hemostasis by PFA-100 (R) analysis in a tertiary care center.” Thrombosis and Haemostasis, August 1, 1999, 743–743.
Munro, Malcom, Ralph Boccia, Arnold Friedman, Lawrence Goodnough, Andra James, Anita Nelson, and Allyson Ocean. “Treatment for Iron Deficiency Anemia Associated With Heavy Menstrual Bleeding,” n.d.